Tumor Markers Research PerspectiveNova Publishers, 2007 - 236 páginas Tumour markers are molecules occurring in blood or tissue that are associated with cancer, and whose measurement or identification is useful in patient diagnosis or clinical management. This book analyses potential signals of cancerous tumours, otherwise known as markers or indicators. This includes, direct and rapid determination of cancer antigen, potential tumour markers for cholangiocarcinoma, melanoma inhibitory activity, metastatic uveal melanoma, measurement of tumour oxygenation, bladder cancer markers, epithelial cell adhesion and progression markers in prostate tumours. |
Índice
| 3 | |
| 19 | |
Measurement of Tumor Oxygenation by Electron Paramagnetic Resonance Oximetry | 37 |
Direct and Rapid Determination of Cancer Antigen 153 in Human Based on Magnetic CoreShell Fe₃O₄SiO₂ Nanoparticles Modified Immunosens... | 53 |
Epithelial Cell Adhesion Molecule EpCAM Past Present and Future | 65 |
Tumour Antigens as Markers of Minimal Residual Disease in Acute Myeloid Leukaemia | 77 |
Usefulness and Limitations of Prostate Specific Antigen for the Detection of Prostate Cancer | 91 |
Increased Expression of Tumor Progresion Markers in Prostate Tumors after Neoadjuvant Hormone Therapy | 103 |
In Search of Bladder Cancer Markers Are Human Papillomavirus and Cellular INK4a Expression Associated? | 135 |
Tumor Markers and Endometriosis | 145 |
Tumor Necrosis Factor Alpha Receptors p55 and p75 in Ovarian Cancer Detection Hope or Myth? | 157 |
Characterization of Breast Cancer Subtypes by Immunohistochemistry in a Large Retrospective Study | 167 |
The Significance of Prognostic Markers in Oral Cancer | 177 |
New Research Communications on Thyroid Tumor Markers | 191 |
Melanoma Inhibitory Activity MIA as a Serological Marker in Metastatic Uveal Melanoma | 203 |
Potential Tumor Marker for Cholangiocarcinoma | 213 |
Hypermethylation of the GSTP1 Gene in Prostate Cancer | 111 |
Polymorphisms in Energy Homeostasis Genes Are Associated with Cutaneous TCell Lymphoma | 125 |
Términos y frases comunes
activity acute analysis antibody antigen applications assessment associated biomarkers blood breast cancer Cancer Res carcinoma cell changes Chapter Clin clinical compared concentrations controls correlation CTCL detection determination diagnosis differentiated disease early effect elevated endometriosis EpCAM epithelial et al evaluated expression factor Figure fluid gene genetic growth GSTP1 head higher histological human identified important improve increase indicator invasive involved leukaemia levels limited luminal malignant mass materials measurement melanoma metastasis metastatic methods methylation molecular monitoring mutations neck normal observed oral ovarian cancer oxygen patients patterns performed positive possible potential predict present profiles prognostic progression promoter prostate cancer protein proteomic radical prostatectomy recent receptor reported response risk role samples screening sensitivity serum showed significant specific specimens stage status subtypes surface Table therapy thyroid tissue treatment tumor markers